Clinical Study of Chidamide Combined With Toripalimab in the Treatment of Advanced Melanoma
Clinical trial NCT05478473 · UNKNOWN
Trial details
- NCT number
- NCT05478473
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-27
- Primary completion
- 2023-08-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.